An animal model of premenstrual dysphoric disorder sensitive to antidepressants

Current Protocols in Neuroscience

Volumn , Issue SUPPL. 46, 2009, Pages

  Schneider, Tomasz ^a   Popik, Piotr ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Animal model; Antidepressants; Irritability; Marble burying test; Premenstrual dysphoric disorder

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DIAZEPAM; ESTRADIOL; ESTROGEN; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; INDALPINE; NEUROSTEROID; NOMIFENSINE; PLACEBO; PROGESTERONE; REBOXETINE; VENLAFAXINE; ZIMELDINE;

ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DRUG SENSITIVITY; ESTRUS CYCLE; HABITUATION; HUMAN; IRRITABILITY; LUTEAL PHASE; MENSTRUAL CYCLE; METESTRUS; MOOD DISORDER; NEUROENDOCRINE SYSTEM; NONHUMAN; OVARY CYCLE; PREMENSTRUAL DYSPHORIC DISORDER; PRIORITY JOURNAL; PROESTRUS;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; ESTROUS CYCLE; FEMALE; FLUOXETINE; HUMANS; MOTOR ACTIVITY; PREMENSTRUAL SYNDROME; PROGESTERONE; PROGESTINS; RATS; RATS, WISTAR; SEROTONIN UPTAKE INHIBITORS;

EID: 59649098584     PISSN: 19348584     EISSN: 19348576     Source Type: Journal    
DOI: 10.1002/0471142301.ns0931s46     Document Type: Article

References (26)

1. American Psychiatric Association, 1994. Diagnostic and Statistical Manual of Mental Disorders, Fourth Ed. American Psychiatric Association, Washington, D.C.
2. Angst, J., Sellaro, R., Merikangas, K.R., and Endicott, J. 2001. The epidemiology of perimenstrual psychological symptoms. Acta Psychiatr. Scand. 104:110-116.
3. Backstrom, T. and Carstensen, H. 1974. Estrogen and progesterone in plasma in relation to premenstrual tension. J. Steroid Biochem. 5:257-260.
4. Bagdy, G., Graf, M., Anheuer, Z.E., Modos, E.A., and Kantor, S. 2001. Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. Int. J. Neuropsychopharmacol. 4:399-408.
5. Baker, E.R., Best, R.G., Manfredi, R.L., Demers, L.M., and Wolf, G.C. 1995. Efficacy of progesterone vaginal suppositories in alleviation of nervous symptoms in patientswith premenstrual syndrome. J. Assist. Reprod. Genet. 12:205-209.
6. Bitran, D., Shiekh, M., and McLeod, M. 1995. Anxiolytic effect of progesterone is mediated by the neurosteroid allopregnanolone at brain GABAA receptors. J. Neuroendocrinol. 7:171-177.
7. Borsini, F., Podhorna, J., and Marazziti, D. 2002. Do animal models of anxiety predict anxiolytic-like effects of antidepressants? Psychopharmacology 163:121-141.
8. Broekkamp, C.L., Rijk, H.W., Joly Gelouin, D., and Lloyd, K.L. 1986. Major tranquillizers can be distinguished from minor tranquillizers on the basis of effects on marble burying and swim-induced grooming in mice. Eur. J. Pharmacol. 126:223-229.
9. Broekkamp, C.L., Berendsen, H.H., Jenck, F., and van Delft, A.M. 1989. Animal models for anxiety and response to serotonergic drugs. Psychopathology 22:2-12.
10. Freeman, E.W. 2004. Luteal phase administration of agents for the treatment of premenstrual dysphoric disorder. CNS Drugs 18:453-468.
11. Freeman, E.W., Rickels, K., Sondheimer, S.J., and Polansky, M. 1995. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome. JAMA 274:51-57.
12. Gallo, M.A. and Smith, S.S. 1993. Progesterone withdrawal decreases latency to and increases duration of electrified prod burial: A possible rat model of PMSanxiety. Pharmacol. Biochem. Behav. 46:897-904.
13. Gyertyan, I. 1995. Analysis of the marble burying response: Marbles serve to measure digging rather than evoke burying. Behav. Pharmacol. 6:24-31.
14. Hashimoto, I., Isomoto, N., Eto, M., Kawaminami, M., Sunazuka, C., and Ueki, N. 1987. Preovulatory secretion of progesterone, luteinizing hormone, and prolactin in 4-day and 5-day cycling rats. Biol. Reprod. 36:599-605.
15. Ho, H.P., Olsson, M., Westberg, L., Melke, J., and Eriksson, E. 2001. The serotonin reuptake inhibitor fluoxetine reduces sex steroid-related aggression in female rats: An animal model of premenstrual irritability? Neuropsychopharmacology 24:502-510.
16. Marcondes, F.K., Bianchi, F.J., and Tanno, A.P. 2002. Determination of the estrous cycle phases of rats: Some helpful considerations. Braz. J. Biol. 62:609-614.
17. Marvan, M.L., Santana, S., Chavez, C.L., and Bertran, M. 1997. Inescapable shocks accentuate fluctuations of forced swimming immobility in different phases of the rat estrous cycle. Arch. Med. Res. 28:369-372.
18. Millan, M.J., Girardon, S., Mullot, J., Brocco, M., and Dekeyne, A. 2002. Stereospecific blockade of marble-burying behaviour in mice by selective, non-peptidergic neurokinin1 (NK1) receptor antagonists. Neuropharmacology 42:677-684.
19. Mishell, D.R. Jr. 2005. Premenstrual disorders: Epidemiology and disease burden. Am. J. Manag. Care 11:S473-S479.
20. Njung'e, K. and Handley, S.L. 1991. Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents. Brit. J. Pharmacol. 104:105-112.
21. Pearlstein, T., Yonkers, K.A., Fayyad, R., and Gillespie, J.A. 2005. Pretreatment pattern of symptom expression in premenstrual dysphoric disorder. J. Affect. Disord. 85:275-282.
22. Schneider, T. and Popik, P. 2007a. Estrous cycle-dependent marble burying in female rats: A model of premenstrual irritability sensitive to antidepressants. Psychoneuroendocrinology 32:651-659.
23. Schneider, T. and Popik, P. 2007b. Increased depressive-like traits in an animal model of premenstrual irritability. Horm. Behav. 51:142-148.
24. Smith, M.S., Freeman, M.E., and Neill, J.D. 1975. The control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rat: Prolactin, gonadotropin and steroid levels associated with rescue of the corpus luteum of pseudopregnancy. Endocrinology 96:219-226.
25. Smith, S.S., Ruderman, Y., Frye, C., Homanics, G., and Yuan, M. 2006. Steroid withdrawal in the mouse results in anxiogenic effects of 3alpha,5beta-THP: A possible model of premenstrual dysphoric disorder. Psychopharmacology 186:323-333.
26. Zohar, J. and Insel, T.R. 1987. Drug treatment of obsessive-compulsive disorder. J. Affect. Disord. 13:193-202.